Tapering or stopping tocilizumab in PMR: Toward optimized treatment withdrawal

Joint Bone Spine. 2025 Dec 18;93(4):106016. doi: 10.1016/j.jbspin.2025.106016. Online ahead of print.

Authors

Baptiste Chevet¹, Valérie Devauchelle-Pensec²

Affiliations

¹ Rheumatology Department, Brest University Hospital, 29200 Brest, France; Inserm 1227, Brest University, Brest, France. Electronic address: baptiste.chevet@chu-brest.fr.
² Rheumatology Department, Brest University Hospital, 29200 Brest, France; Inserm 1227, Brest University, Brest, France.

PMID: 41421728
DOI: 10.1016/j.jbspin.2025.106016

No abstract available

Keywords: BDMARD; Polymyalgia rheumatica; Tocilizumab; Treatment; Withdrawal.

Publication types

Editorial